Child Health

1 Active

1 results

Active
An open‐label extension study to evaluate the long‐term safety, tolerability and efficacy of Marstacimab prophylaxis in severe (coagulation factor activity <1%) hemophilia A participants with or without inhibitors or moderately severe to severe hemophilia B participants (coagulation factor Activity ≤2%) with or without inhibitors
Wali, Y.
3/1/21 → …
Project: Other project